Pascual M, López-Nevot M A, Cáliz R, Ferrer M A, Balsa A, Pascual-Salcedo D, Martín J
Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
Arthritis Rheum. 2003 Mar;48(3):638-41. doi: 10.1002/art.10864.
To investigate the association of the poly(ADP-ribose) polymerase 1 (PARP-1) gene promoter polymorphism with rheumatoid arthritis (RA) predisposition.
An association study with 213 Spanish RA patients and 242 healthy subjects was carried out to investigate the association of all known PARP-1 gene promoter polymorphisms, i.e., a CA microsatellite repeat, a poly(A)(n), and 3 single point mutations (C410T, C1362T, and G1672A), with disease susceptibility. Additionally, we analyzed the distribution of PARP-1 polymorphisms in 58 Spanish families with 1 or more affected members.
Upon complete genotyping of the panel of 455 samples, strong linkage disequilibrium was observed among the 5 PARP-1 polymorphisms. Only 2 PARP-1 haplotypes were detected: haplotype A (410T-A-CA-1362C, which includes short PARP-1 CA alleles) and haplotype B (410C-A-CA-1362T, always paired with long PARP-1 CA variants). Regarding the G1672A variation, although linkage disequilibrium was detected, it did not seem to be part of the conserved haplotypes described. Haplotype B was statistically overrepresented in the RA patient group compared with the healthy subjects (odds ratio 1.42, 95% confidence interval 1.06-1.91, P = 0.019). In addition, a significant dose effect of PARP-1 haplotype carriage on disease predisposition was observed. Of note, within haplotype B, the PARP-1 CA 97-bp allele was found to be the RA-predisposing marker (odds ratio 2.17, 95% confidence interval 1.27-3.72, P = 0.003, corrected P < 0.05).
Our results demonstrate the existence of 2 unique PARP-1 haplotypes in the Spanish population and provide the first evidence that PARP-1 haplotypes play a role in susceptibility to RA.
研究聚(ADP - 核糖)聚合酶1(PARP - 1)基因启动子多态性与类风湿关节炎(RA)易感性之间的关联。
对213名西班牙RA患者和242名健康受试者进行关联研究,以调查所有已知的PARP - 1基因启动子多态性,即CA微卫星重复序列、聚(A)(n)以及3个单点突变(C410T、C1362T和G1672A)与疾病易感性的关系。此外,我们分析了58个有1名或多名患病成员的西班牙家庭中PARP - 1多态性的分布情况。
在对455个样本进行完全基因分型后,观察到5种PARP - 1多态性之间存在强连锁不平衡。仅检测到2种PARP - 1单倍型:单倍型A(410T - A - [CA](10 - 12) - 1362C,其中包括短PARP - 1 CA等位基因)和单倍型B(410C - A - [CA](13 - 20) - 1362T,总是与长PARP - 1 CA变体配对)。关于G1672A变异,虽然检测到连锁不平衡,但它似乎不是所描述的保守单倍型的一部分。与健康受试者相比,单倍型B在RA患者组中的统计学代表性过高(优势比1.42,95%置信区间1.06 - 1.91,P = 0.019)。此外,观察到PARP - 1单倍型携带对疾病易感性有显著的剂量效应。值得注意的是,在单倍型B中,PARP - 1 CA 97 - bp等位基因被发现是RA易感性标志物(优势比2.17,95%置信区间1.27 - 3.72,P = 0.003,校正后P < 0.05)。
我们的结果证明了西班牙人群中存在2种独特的PARP - 1单倍型,并首次提供了PARP - 1单倍型在RA易感性中起作用的证据。